Trinity Biotech (TRIB) Return on Capital Employed (2009 - 2024)
Trinity Biotech recorded quarterly Return on Capital Employed of 31.0% in Q4 2024, down 56.6% quarter-over-quarter from 19.79% in Q3 2024, and up 2720.0% year-over-year from 1.1% in Q1 2024.
Trinity Biotech's Return on Capital Employed history runs 16 years deep, the most recent figure standing at 31.0% for Q4 2024.
- In Q4 2024, Return on Capital Employed rose 2720.0% year-over-year to 31.0%; the TTM figure through Dec 2024 stood at 31.0% (up 2720.0% YoY), while the FY2025 annual figure was 42.69%, up 8565.0% from the prior year.
- Return on Capital Employed came in at 31.0% for Q4 2024 at Trinity Biotech, down from 19.79% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 86.72% in Q2 2021 to a low of 58.2% in Q4 2023.
- A 5-year average of 5.08% and a median of 5.91% in 2022 frame the typical range for Return on Capital Employed.
- Across the five-year window, Return on Capital Employed soared 8204 bps in 2021 and plunged 8644 bps in 2022, its largest moves.
- Trinity Biotech's Return on Capital Employed stood at 19.16% in 2020, then surged by 70 bps to 32.57% in 2021, then tumbled by 177 bps to 24.92% in 2022, then sank by 134 bps to 58.2% in 2023, then jumped by 47 bps to 31.0% in 2024.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 31.0%, 19.79%, and 23.09% for Q4 2024, Q3 2024, and Q2 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 7.62% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 11.57% |
| 10 | Trinity Biotech | 28,000.00 | -5.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -31.00% |
| Sep 30, 2024 | -19.79% |
| Jun 30, 2024 | -23.09% |
| Mar 31, 2024 | -50.28% |
| Dec 31, 2023 | -58.20% |
| Sep 30, 2023 | -57.08% |
| Jun 30, 2023 | -52.47% |
| Mar 31, 2023 | -29.22% |
| Dec 31, 2022 | -24.92% |
| Sep 30, 2022 | -12.11% |
| Jun 30, 2022 | 0.29% |
| Mar 31, 2022 | 2.42% |
| Dec 31, 2021 | 32.57% |
| Sep 30, 2021 | 72.48% |
| Jun 30, 2021 | 86.72% |
| Mar 31, 2021 | 21.40% |
| Dec 31, 2020 | 19.16% |
| Sep 30, 2020 | 11.64% |
| Jun 30, 2020 | 4.68% |
| Mar 31, 2020 | 5.25% |
| Dec 31, 2019 | 4.00% |
| Sep 30, 2019 | 3.94% |
| Jun 30, 2019 | 3.84% |
| Mar 31, 2019 | 4.36% |
| Dec 31, 2018 | 4.46% |
| Sep 30, 2018 | 3.32% |
| Jun 30, 2018 | 3.38% |
| Mar 31, 2018 | 3.48% |
| Dec 31, 2017 | 2.77% |
| Sep 30, 2017 | 2.38% |
| Jun 30, 2017 | 2.91% |
| Mar 31, 2017 | 3.08% |
| Dec 31, 2016 | 2.68% |
| Sep 30, 2016 | 2.96% |
| Jun 30, 2016 | 3.04% |
| Mar 31, 2016 | 3.22% |
| Dec 31, 2015 | 3.99% |
| Sep 30, 2015 | 4.33% |
| Jun 30, 2015 | 5.76% |
| Mar 31, 2015 | 7.97% |
| Dec 31, 2014 | 8.28% |
| Sep 30, 2014 | 8.37% |
| Jun 30, 2014 | 8.65% |
| Mar 31, 2014 | 8.44% |
| Dec 31, 2013 | 8.43% |
| Sep 30, 2013 | 8.80% |
| Jun 30, 2013 | 8.63% |
| Mar 31, 2013 | 9.09% |
| Dec 31, 2012 | 9.50% |
| Sep 30, 2012 | 9.75% |
| Jun 30, 2012 | 9.81% |
| Mar 31, 2012 | 9.85% |
| Dec 31, 2011 | 10.04% |
| Sep 30, 2011 | 9.76% |
| Jun 30, 2011 | 9.39% |
| Mar 31, 2011 | 9.40% |
| Dec 31, 2010 | 9.53% |
| Sep 30, 2010 | 9.81% |
| Jun 30, 2010 | 11.11% |
| Mar 31, 2010 | 13.81% |
| Dec 31, 2009 | 13.33% |
| Sep 30, 2009 | -75.38% |
| Jun 30, 2009 | -81.11% |
| Mar 31, 2009 | -82.88% |